Showing results (171-180 of 182) with videos related to
Sort By:
Pageof 19
Vaccine|November 2, 2023
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)Julia M Neuhann, Jannik Stemler, Antonio J Carcas, et al.Nature Cancer|April 15, 2022
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancerCiric To, Tyler S Beyett, Jaebong Jang, et al.BMC Biology|April 10, 2023
Genome-wide association reveals host-specific genomic traits in Escherichia coliSumeet K Tiwari, Boas C L van der Putten, Thilo M Fuchs, et al.Nature|December 20, 2003
A gravitationally lensed quasar with quadruple images separated by 14.62 arcsecondsNaohisa Inada, Masamune Oguri, Bartosz Pindor, et al.Cancer Discovery|April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET InhibitorsFederica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.Science Translational Medicine|September 13, 2021
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancerPınar Özden Eser, Raymond M Paranal, Jieun Son, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.Cancer Cell|January 15, 2020
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic PathwayKari J Kurppa, Yao Liu, Ciric To, et al.Vaccine|May 20, 2023
VACCELERATE Site Network: Real-time definition of clinical study capacity in EuropeJon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, et al.Pageof 19